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Abstract 
Trypanosoma brucei stumpy forms are the only stage that can transmit from human to tsetse 
fly. Stumpy formation is regulated by a quorum sensing mechanism that depends on parasite 
density and an unknown stumpy induction factor (SIF). Recently, an elegant study by 
Matthews and colleagues has identified several crucial components of this pathway including 
the putative SIF and its receptor.  
 
 
 
   
The protozoan parasite Trypanosoma brucei causes sleeping sickness in humans and nagana 
in animals in sub-Saharan Africa. Trypanosomes cycle between a mammalian host and an 
arthropod vector, the tsetse fly, thereby transitioning through various environments. 
Importantly a subset of parasites switches from a replicative, slender form in the human 
blood stream to a non-replicative stumpy form that is competent for transmission to the 
tsetse fly. Stumpy forms undergo drastic morphologic and metabolic changes in preparation 
for further development in the tsetse fly’s midgut.  
 
Proposed more than 20 years ago, various lines of evidence have established the paradigm 
that quorum sensing regulates the level of stumpy formation. In this model slender forms 
have the capacity to sense their density in the host (and in vitro) based on the abundance of 
a soluble factor termed stumpy induction factor (SIF) [1]. Earlier experiments also 
demonstrated that SIF is transduced in the parasite through cyclic AMP-dependent signalling 
[2]. A genome-wide RNAi screen has recently identified more than 30 activators and 
repressors of the SIF pathway, finally providing the basis for a systematic dissection of the 
downstream factors required for stumpy formation [3]. A series of subsequent studies have 
started to validate several of these factors, including the serine/threonine phosphatase PPT1 
and the RNA binding protein RBP7 and placed them in a non-linear hierarchy of the SIF 
pathway [4]. So far, the nature of SIF remained elusive.   
 
A recent study by Matthews and colleagues represents a major step towards defining the SIF 
pathway. In their study the T. brucei ortholog of the mammalian G protein coupled-receptor 
(GPCR) protein GPR89 is identified as an essential surface antigen required for parasite 
survival and stumpy formation. Inspection of the protein revealed that TbGPR89 has both a 
GPCR and an oligopeptide transporter domain (with homology to bacterial proton-coupled 
peptide transporters POT), suggesting that it has a dual function as a receptor and 
transporter. In contrast, other Trypanosoma species lacking density-dependent growth 
control have two separate proteins, a POT and a GPR89 ortholog. Trypanosomes are known 
to secrete peptidases into their environment during infection, generating unusual 
oligopeptides in the blood stream [5]. Indeed, analysis of the secretome of T. brucei identified 
multiple secreted peptidases [6], with proposed function in modulating host immunity and 
pathogenesis [7]. The new study by Rojas et al. demonstrates that TbGPR89 is an 
oligotransporter for oligopeptide substrates that are produced by secreted peptidases. 
Importantly, inducible expression of such secreted peptidases can induce stumpy formation. 
Altogether these data demonstrate that secreted peptidases can generate a paracrine 
quorum sensing signal in the form of oligopeptides that is internalised by TbGRP89 and can 
subsequently lead to stumpy formation, recapitulating all the hallmarks of SIF.  
 
The study by Rojas et al. represents a major breakthrough towards defining the elusive SIF 
and its receptor, and as such it closes a critical knowledge gap in the parasite cycle. The 
authors propose a model where levels of secreted peptidases (essentially a proxy for 
parasitemia) determine the concentration of oligopeptides in the parasite environment. 
These oligopeptides are taken up by recipient cells via TbGRP89, and once they reach a certain 
threshold induce stumpy differentiation in recipient cells (Figure 1). However, many open 
questions remain that will need to be addressed in future studies. First, it is not clear whether 
parasites are sensitive to the oligopeptide concentration or the type of oligopeptides they are 
exposed to (or a combination thereof).  Second, experiments were performed under in vitro 
conditions and in the mouse model where a significantly higher parasitemia is reached than 
during human infection. Therefore, a localized rather than systemic concentration of 
oligopeptides is more likely to be critical under physiological conditions. Recent studies have 
demonstrated parasite homing to skin [8] and adipose tissues [9] where stumpy formation is 
promoted. Given the new findings, this may be the result of increased local concentration of 
oligopeptides in these microenvironments. Such a scenario is similar to the recently described 
regulation of gametocyte formation in the malaria parasite, Plasmodium falciparum via the 
serum phospholipid lysophosphatidylcholine (LysoPC) [10]. While reduced systemic levels of 
LysoPC are mainly induced by inflammation (hence a putative trigger of differentiation) they 
are intrinsically lower in the bone marrow niche, where gametocyte levels are high. Third, it 
is unclear how TbGRP89 itself is regulated to fine tune its dual function as transporter and 
sensor. Investigation of the functional domains of TbGPR89 identified putative 
phosphorylation and glycosylation sites that could regulate its activity, possibly via the known 
SIF signalling factors PP1 and MEKK1. Finally, this important study opens new avenues for 
drug development: as TbGRP89 is essential both for parasite survival and stumpy formation, 
a Tb-GRP89-targeting drug could potentially reduce parasite burden and at the same time 
block transmission. 
 
  
Figure 1. A putative model of stumpy formation based on the recent findings. Parasite 
density correlates with secreted protease activity, and hence the levels of oligopeptides in 
the extracellular environment of the parasite. These oligopeptides, the putative SIF, are 
sensed and internalized by recipient parasites through the putative SIF receptor, TbGPR89. At 
high parasitemia accumulation of oligopeptides activates signaling pathways (e.g., MEEK1, 
NEK1, PP1, YAK, RBP7…) that lead to stumpy formation. At lower cell density, less 
oligopeptides are produced and internalized thus activating an alternative pathway (e.g., 
TOR4, ZFK, MAPK5 …) that represses stumpy formation and keeps the cell in a replicative 
state, the slender form.  
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